Bedfont® Scientific Limited, an innovative med-tech company specializing in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring whether enhanced asthma ...
Umeclidinium-Vilanterol Inhaler May Reduce COPD Exacerbations Compared With Other LAMA-LABA Inhalers
Researchers conducted an observational study using real‑world data to compare the effectiveness and safety of initiating three fixed‑dose long‑acting muscarinic antagonist (LAMA)-long‑acting beta‑2 ...
Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Residents of the Gray's Landing apartments argued that federal officers have inundated the building with chemical munitions ...
A new U.S. study found Anoro Elipta to be better than Bevespi Aerosphere or Stiolto Respimat at lowering the risk of disease flares in COPD.
"Today's approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment," said Iilun Murph ...
Sometimes the story can be told in statistics. India accounts for 13% of the global population, yet it accounts for 42% of global asthma mortality. Around 35 million Indians are thought to be living ...
Umeclidinium-vilanterol is associated with improved clinical outcomes in symptomatic patients with chronic obstructive pulmonary disease.
Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...
Just over a month ago, I had a CT scan of my chest which revealed considerably more than I expected. I knew I suffered from asthma – I have done since the age of four. I also knew I had broken the T8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results